Johnson & Johnson has officially raised its financial projections for the full year 2026, demonstrating remarkable resilience in the face…
Read More
The Vagus Nerve Stimulation Breakthrough: How Body-Brain Communication Could Revolutionize Skill Acquisition
Why do some new skills seem to click almost instantly while others remain frustratingly difficult even after repeated practice? The…
Read More
Viatris Expands Into Non-Opioid Pain Market With $1.65bn Acquisition of Pacira BioSciences
The global pharmaceutical landscape is undergoing a profound structural shift as healthcare enterprises aggressively pivot away from traditional opioid-based narcotics…
Read More
Shionogi Expands Rare Disease Portfolio With $2 Billion Acquisition of IntraBio and Flagship Drug Aqneursa
Japanese pharmaceutical major Shionogi has announced a definitive agreement to acquire IntraBio in a multibillion-dollar transaction valued at $2 billion.…
Read More
The Vagus Nerve Stimulation Breakthrough: How Body-Brain Communication Could Revolutionize Skill Acquisition
Why do some new skills seem to click almost instantly while others remain frustratingly difficult even after repeated practice? For…
Read More
Made Scientific Expands US East Coast Footprint with Acquisition of Advanced Pennsylvania Cell Therapy Manufacturing Facility from National Resilience
The landscape of advanced therapeutics manufacturing received a significant boost as Made Scientific officially acquired an expansive 85,000-square-foot cell therapy…
Read More
Samsung Biologics Accelerates Global Expansion with Strategic US Acquisition and PolyPeptide Deal
South Korean contract development and manufacturing organization (CDMO) Samsung Biologics has embarked on a significant phase of global expansion, marked…
Read More
Repetition Really Matters: Elbow Writing Study Reveals the Power of Practice in Skill Acquisition
The common understanding of human motor skill development has long acknowledged a natural, innate preference for using one side of…
Read More
Talawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
In a significant development poised to reshape the landscape of immunology therapeutics, New Jersey-based Talawar Therapeutics has officially merged with…
Read More
Biogen Pauses or Terminates Investment in Most of Apellis’ Legacy Research Programs Following $5.6 Billion Acquisition
Three months after Biogen finalized its substantial $5.6 billion acquisition of Apellis Pharmaceuticals, a significant shift in research and development…
Read More
